On August 10, 2023, CJ Bioscience, Inc., closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
13,920 KRW | -1.49% | 0.00% | -13.75% |
1st Jan change | Capi. | |
---|---|---|
-13.75% | 95.16M | |
+41.79% | 50.93B | |
-0.56% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+12.59% | 26.02B | |
-21.51% | 18.9B | |
+6.92% | 13.21B | |
+24.91% | 12.17B | |
+29.60% | 12.16B |
- Stock Market
- Equities
- A311690 Stock
- News CJ Bioscience, Inc.
- CJ Bioscience, Inc. announced that it has received KRW 24.033 billion in funding from CJ Cheiljedang Corporation